The body can store several years’ worth of vitamin B12 in the liver. The type of B12 used affects how long it remains in the body. Hydroxocobalamin, more common in Europe, is retained longer than cyanocobalamin, which is more common in the United States.
Research in patients with confirmed deficiency has shown that a 1,000 microgram injection results in significantly greater retention than a 100 microgram dose, without increasing cost or toxicity. This supports the now-common practice of using high-dose injections.
For newly diagnosed patients, a loading phase is essential to replenish vitamin B12 stores quickly. Clinical research recommends five to six injections of 1,000 micrograms cyanocobalamin given biweekly during the first month of treatment.
Hydroxocobalamin dosing protocols typically begin with five 1 milligram injections given on alternate days before transitioning to maintenance dosing. Both regimens have been shown to produce rapid normalization of serum B12 and symptom improvement in statistically significant patient groups.
Once body stores are replenished, maintenance therapy aims to keep B12 levels within the normal range and prevent symptom recurrence. Evidence supports a maintenance dose of 1,000 micrograms monthly for cyanocobalamin, or every two to three months for hydroxocobalamin.
While clinical guidelines set conservative maintenance intervals, patient surveys reveal a different picture. In a study of 192 B12-deficient patients, daily or weekly injections resulted in greater symptom improvement than monthly or less frequent dosing. Adding oral B12 to injection regimens further improved outcomes.
Similarly, in patients with myalgic encephalomyelitis or fibromyalgia, more frequent and higher-dose B12 injections combined with high-dose folic acid were associated with significantly better self-reported improvement. In both cases, the differences between higher- and lower-frequency regimens were statistically significant.
The optimal dosage and frequency of vitamin B12 injections are supported by strong clinical evidence, yet real-world practice often deviates from these guidelines. While most patients do well with monthly or less frequent maintenance dosing, some may require shorter intervals based on symptoms. The safest and most effective approach combines laboratory monitoring, symptom tracking, and patient-specific adjustments.